In our Regulatory Snapshot, when we say a country treats Medicinal Cannabis as restricted, it means that products like cannabidiol (CBD) oils are only allowed under formal medicine registration rules. This does not exclude other interpretations, where the same CBD oil may be seen as a herbal medicine, supplement, or even a superfood. In many countries, this remains a “grey area” — a space where entrepreneurs must actively engage and help shape the path forward.
What you'll learn
Table of contents
Brazil Introduction
Brazil is a vast and diverse country with complex regulation around cannabis. While recreational use remains officially illegal, significant legal reforms and judicial rulings (like the Supreme Court’s decriminalization of small amounts) reflect shifting enforcement priorities. The medical cannabis sector is highly regulated but growing, and the industrial hemp sector has just received judicial clearance with formal regulation still pending.
---
Cannabis & Wellness Regulation Overview
Recreational Cannabis (Adult Use)
Status: Decriminalized small personal use.
- The Supreme Federal Court ruled in June 2024 that possession of up to 40 grams or 6 female cannabis plants should be considered personal use and subject only to administrative sanctions, not criminal penalties. - Public use and sale remain illegal and punishable under criminal law.
Medical Cannabis
Status: Controlled medical access.
- Regulated by ANVISA’s RDC 327 (2019) and expanded with RDC 660 (2022).
- Products must be pharmaceutically standardized, sold via pharmacies, and require medical prescription. Mevatyl (Sativex®) is available; more products are entering the market.
Hemp Definition & Industrial Use
Status: Legal but pending regulation.
- In late 2024, the STJ ruled that industrial hemp (low-THC Cannabis sativa) could be cultivated for medicinal/pharmaceutical purposes; ANVISA has until May 2025 to regulate this.
- Cultivation, processing, and commercial use await final regulatory framework.
Cosmetics & Artisanal Products
Status: Restricted.
- Cannabis-derived active ingredients (CBD, THC) are not permitted in cosmetics under ANVISA rules.
- Hemp seed oil (Cannabis sativa seed oil), which contains no cannabinoids, is allowed as a cosmetic ingredient and can be used like any other plant oil.
- All cosmetics must comply with ANVISA’s general cosmetic regulations (registration/notification, labeling, safety testing).
Functional Mushrooms & Adaptogens
Status: Unregulated.
- Functional mushrooms fall under food/supplement regulation and are not restricted. Standard food safety and labeling laws apply.
Psilocybin / Psychedelics
Status: Prohibited.
- Psilocybin remains classified as a controlled substance with no legal framework for medical or decriminalized use.
---
Click here to explore our kiosk model (One-Stop Shop Cannabis) for shopping centers in Brazil.
Operating Guidance (Hemp Vegan)
Wellness-Driven Coffee & Retail
Beyond coffee. Hemp Vegan adapts to your locality, offering wellness products aligned with local compliance:
- Choose your space: café, wellness hub, hybrid.
- Plug into the ecosystem: superfoods, functional mushrooms, pharma-compliant cannabis medicines, emerging hemp opportunities.
- Grow with support: regulatory roadmap, SOPs, ongoing training.
Clinical Tools & AI
Psilocybin-ready frameworks and AI clinical tools for professionals—strong compliance where regulated, guided entry where not.
---
Marketing, Claims & Compliance
Advertising & Claims
- No medical claims without authorization.
- Use structure/function or educational framing.
- Disclaimers essential; onsite validation for medical products.
Packaging & Labeling
- Required: ingredients, lot, expiry, dosage, prescriber info.
- Medical cannabis packaging is pharmaceutical-grade with traceability tracking.
---
Taxes, Import & Duties
- VAT/ICMS varies by state (approx. 17–20%).
- Medical cannabis is sold via pharmacies under healthcare supply chains.
- Industrial hemp import/export requires future regulation.
---
Risks & Practical Notes
- Cannabis: personal use tolerated; sale remains high-risk.
- Medical: regulated but accessible under RDC framework.
- Hemp: legal path established, but policy still pending.
- Strategy: start with functional mushrooms, pharma medical products, then pivot into hemp when regulated.
---
FAQ (Hemp Vegan)
How Hemp Vegan supports operations in Brazil
We clarify what’s permissible today (medical cannabis, mushrooms), what’s conditional (hemp pending ANVISA rules), and what’s prohibited (recreational sale, psychedelics). We deliver SOPs, training, and local ecosystem support.
Local operations & compliance
Brazil requires local entity + ANVISA authorizations for cannabis operations. Hemp Vegan assists with local licensing strategy and partner networks.
Creators vs. Employees
Retail and clinics operate via local staff or vetted contractors. We provide legal contract templates and compliance checks.
Ongoing updates
Brazil’s regulation evolves rapidly. We offer continuous updates, trainings, and legal alerts to partners.
---
Sources & Review Log
_Last reviewed_: 2025-08-23
- ANVISA RDC 327/2019 & RDC 660/2022 — medical cannabis framework
- Supreme Court decriminalization decision (RE 635659) — personal use thresholds
- STJ ruling on industrial hemp and pending regulation
- CMS Expert Guide — medical cannabis import/manufacturing compliance
